electroCore, Inc. stock is down -10.24% since 30 days ago. The next earnings date is Mar 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 16.67% of the previous 5 November’s closed higher than October. 100% of analysts rate it a buy.
electroCore is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.